- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 33/242 - GoldCompounds thereof
Patent holdings for IPC class A61K 33/242
Total number of patents in this class: 301
10-year publication summary
|
1
|
2
|
9
|
20
|
44
|
50
|
53
|
42
|
30
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shenzhen Profound View Pharmaceutical Technology Co., Ltd. | 20 |
14 |
| Nanobiotix | 116 |
8 |
| The Regents of the University of California | 20230 |
5 |
| The General Hospital Corporation | 4792 |
5 |
| Northwestern University | 3442 |
5 |
| Galera Labs, LLC | 53 |
5 |
| University of Notre Dame du Lac | 582 |
5 |
| Medsenic | 10 |
5 |
| Shenzhen Profound-View Pharma Tech Co., Ltd | 13 |
5 |
| Arizona Board of Regents on behalf of Arizona State University | 2712 |
4 |
| Case Western Reserve University | 1844 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6509 |
3 |
| Board of Regents, The University of Texas System | 5917 |
3 |
| Clene Nanomedicine, Inc. | 32 |
3 |
| Universidad de Chile | 171 |
3 |
| University of Kentucky Research Foundation | 698 |
3 |
| Varian Medical Systems, Inc. | 865 |
3 |
| Seoul National University R&db Foundation | 3743 |
3 |
| Goldred Nanobiotech Co., Ltd. | 4 |
3 |
| Wuhan Vast Conduct Science Foundation Co., Ltd. | 14 |
3 |
| Other owners | 209 |